Cargando…

Current and recent clinical trials for perioperative systemic therapy for muscle invasive bladder cancer: a systematic review

BACKGROUND: Although Muscle Invasive Bladder Cancer (MIBC) is increasing in incidence, treatment has largely remained limited to radical cystectomy with or without cisplatin-based neoadjuvant and/or adjuvant chemotherapy. We reviewed the current and recent clinical trials evaluating perioperative ch...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vashistha, Vishal, Quinn, David I, Dorff, Tanya B, Daneshmand, Siamak
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4301463/ https://www.ncbi.nlm.nih.gov/pubmed/25515347 http://dx.doi.org/10.1186/1471-2407-14-966

Ejemplares similares

Perioperative therapy in muscle invasive bladder cancer
por: Chatterjee, Ambarish, et al.
Publicado: (2021)

Current and Future Landscape of Perioperative Treatment for Muscle-Invasive Bladder Cancer
por: Esteban-Villarrubia, Jorge, et al.
Publicado: (2023)

Perioperative systemic therapy in muscle invasive bladder cancer: Current standard method, biomarkers and emerging strategies
por: Kim, Kyung Hwan, et al.
Publicado: (2023)

Perioperative immunotherapy for muscle-invasive bladder cancer
por: Kim, In-Ho, et al.
Publicado: (2020)

Perioperative immunotherapy in muscle-invasive bladder cancer
por: Lee, Hyung Ho, et al.
Publicado: (2020)

Perioperative Systemic Treatment for Muscle-Invasive Bladder Cancer: Current Evidence and Future Perspectives
por: Kim, In-Ho, et al.
Publicado: (2021)

Adenomatous Polyp of the Verumontanum Causing Bladder Outlet Obstruction
por: Daneshmand, Siamak
Publicado: (2004)

3512 Identifying Patient-Level Barriers to Non-Muscle Invasive Bladder Cancer Treatment and Surveillance Adherence in Low-Income Latino Patients: A Mixed-Methods Study
por: Bhanvadia, Sumeet Kaur, et al.
Publicado: (2019)

Emerging perioperative therapeutic approaches in muscle invasive bladder cancer
por: Patil, Goutham, et al.
Publicado: (2022)

Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trial
por: Galsky, Matthew D., et al.
Publicado: (2023)

Role of Perioperative Immune Checkpoint Inhibitors in Muscle Invasive Bladder Cancer
por: Chhaya, Saachi, et al.
Publicado: (2023)

A Novel DNA Methylation Signature as an Independent Prognostic Factor in Muscle-Invasive Bladder Cancer
por: Xu, Zhijie, et al.
Publicado: (2021)

Estimating the optimal perioperative chemotherapy utilization rate for muscle‐invasive bladder cancer
por: Karim, Safiya, et al.
Publicado: (2019)

Pharmacologic Therapies for Non-Muscle Invasive Bladder Cancer: Current and Future Treatments
por: Goldberg, Ilana P., et al.
Publicado: (2022)

Patterns of Bladder Preservation Therapy Utilization for Muscle-Invasive Bladder Cancer
por: Rose, Tracy L., et al.
Publicado: (2016)

The Current Progress and Future Options of Multiple Therapy and Potential Biomarkers for Muscle-Invasive Bladder Cancer
por: Shi, Ying, et al.
Publicado: (2023)

Androgen deprivation therapy for prostate cancer: long-term safety and patient outcomes
por: Ahmadi, Hamed, et al.
Publicado: (2014)

The impact of patient-related nonmodifiable factors on perioperative outcomes following radical cystectomy with enhanced recovery protocol
por: Zainfeld, Daniel, et al.
Publicado: (2018)

The current role of circulating biomarkers in non-muscle invasive bladder cancer
por: Rink, Michael, et al.
Publicado: (2019)

Perioperative chemotherapy for muscle-invasive bladder cancer: the importance of multidisciplinary management for evidence-based practice and transformative research
por: Koshkin, Vadim S., et al.
Publicado: (2018)

Quality indicators for the management of muscle-invasive bladder cancer in the perioperative setting of radical cystectomy: a narrative review
por: König, Frederik, et al.
Publicado: (2022)

Bone-targeted therapies to reduce skeletal morbidity in prostate cancer
por: Dorff, Tanya B, et al.
Publicado: (2018)

Bladder Preservation for Muscle Invasive Bladder Cancer
por: Mirza, Arafat, et al.
Publicado: (2016)

Clinical use of cabozantinib in the treatment of advanced kidney cancer: efficacy, safety, and patient selection
por: Yu, Steven S, et al.
Publicado: (2016)

Transurethral resection of bladder tumor-based bladder preservation therapy for refractory high risk non-muscle invasive bladder cancer: Current landscape and future directions
por: Sun, Xinghui, et al.
Publicado: (2023)

Management Trends and Outcomes of Patients Undergoing Radical Cystectomy for Urothelial Carcinoma of the Bladder: Evolution of the University of Southern California Experience over 3,347 Cases
por: Mitra, Anirban P., et al.
Publicado: (2022)

Current status of genetic urinary biomarkers for surveillance of non-muscle invasive bladder cancer: a systematic review
por: Lozano, F., et al.
Publicado: (2020)

Biomarkers for non-muscle invasive bladder cancer: Current tests and future promise
por: Darwiche, Fadi, et al.
Publicado: (2015)

Review of current optical diagnostic techniques for non-muscle-invasive bladder cancer
por: Kołodziej, Anna, et al.
Publicado: (2016)

Non-Muscle Invasive Bladder Cancer: A Review of the Current Trend in Africa
por: Cassell, Ayun, et al.
Publicado: (2019)

Neoadjuvant immunotherapy for muscle invasive urothelial bladder carcinoma: will it change current standards?
por: Renner, Alex, et al.
Publicado: (2021)

The Effect of Tri-Modality Therapy with Bladder Preservation for Selective Muscle-Invasive Bladder Cancer
por: Zhiyu, Zhang, et al.
Publicado: (2021)

Perioperative Safety of Bladder Hydrodistention in Patients on Antithrombotic Therapy
por: Peng, Liao, et al.
Publicado: (2023)

Optimizing Diagnosis of Urothelial Bladder Cancer with Blue Light Cystoscopy via Recognition of False-Positive Lesions
por: Bazargani, Soroush T., et al.
Publicado: (2018)

Systematic Review and Meta-Analysis on the Efficacy of Chemotherapy with Transurethral Resection of Bladder Tumors as Definitive Therapy for Muscle Invasive Bladder Cancer
por: Moran, George W., et al.
Publicado: (2017)

Bladder-sparing approaches for muscle invasive bladder cancer: a narrative review of current evidence and future perspectives
por: Fan, Xinxiang, et al.
Publicado: (2023)

Bladder Sparing Approaches for Muscle-Invasive Bladder Cancers
por: El-Taji, Omar M. S., et al.
Publicado: (2016)

Association of age with response to preoperative chemotherapy in patients with muscle-invasive bladder cancer
por: D’Andrea, David, et al.
Publicado: (2021)

Performance of Narrow Band Imaging (NBI) and Photodynamic Diagnosis (PDD) Fluorescence Imaging Compared to White Light Cystoscopy (WLC) in Detecting Non-Muscle Invasive Bladder Cancer: A Systematic Review and Lesion-Level Diagnostic Meta-Analysis
por: Russo, Giorgio I., et al.
Publicado: (2021)

Collagen stiffness promoted non-muscle-invasive bladder cancer progression to muscle-invasive bladder cancer
por: Zhu, Huier, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_q80oh8so2f5iln7541uufi2gr6